Skip to content

Evaluation of the Mobility Monitor as an aid in the care of geriatric patients with cognitive impairments and tendencies to get out of bed in a hospital

Evaluation of the Mobility Monitor as an aid in the care of geriatric patients with cognitive impairments and tendencies to get out of bed in a hospital - MoMo-BA

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00027525
Enrollment
25
Registered
2022-02-25
Start date
2022-03-14
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The nursing benefit of the use of the bed sensor system Mobility Monitor with bed exit information in the care of patients with cognitive impairments and adverse bed exit tendencies is examined.

Interventions

Group 1: In the first phase (phase 0), these patients are cared for over a period of six weeks without using the MoMo. A daily anonymised prevalence survey of the number of patients with cognitive i

Sponsors

Universitätsklinikum FreiburgPflegedirektion
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: All nursing staff who work in the geriatric ward of the at the University Medical Center Freiburg during the study period.

Exclusion criteria

Exclusion criteria: All staff of the geriatric ward at the Freiburg University Medical Hospital who belong to other professional groups.

Design outcomes

Primary

MeasureTime frame
Benefit aspects (positive effects and disadvantages or risks) of the use of MoMo from a nursing perspective: ? Physical and psychological stress of caregivers, ? impact on the care process, ? impact on patient outcome, ? impact on the perception of autonomy and privacy of patients with cognitive impairment. The study is carried out as a mixed-methods approach at different points in time or in different time periods: ? End of phase 0 (T 0, approximately week 5-6): observation of one to two trainings of nursing staff on MoMo followed by a group discussion. ? Accompanying during the use of MoMo (phase 1, weeks 7-24): accompanying study diary for anonymous recording of situational challenges in the use of MoMo. ? After the end of the 18-week MoMo use phase (T 1.1, approximately week 25-30): online survey of nursing staff. ? After the end of the 18-week MoMo use phase (T 1.2, approximately week 26-35): One to two group discussions with nursing staff.

Secondary

MeasureTime frame
1. Attitudes of nursing staff towards technological innovations in general and technological aids in nursing in particular. 2. Nursing staff's acceptance of technological innovations in general and technological aids in care in particular. 3. Attitudes of nursing staff towards the MoMo as an aid in care. 4. Nursing staff's acceptance of the MoMo as an aid in care. 5. Inhibiting and promoting factors in the use of aids or in terms of perceived benefits. 6. Changes in the interaction between nursing staff and patients. 7. Ethical aspects of the use of assistive devices. 8. Use scenarios, criteria or decision algorithms for the application of the bed exit module of the MoMo. 9. Number of patients with cognitive impairments and number of adverse events in patients with cognitive impairments, without and with the use of the MoMo in relation to the number of patients with cognitive impairments. 10. Number of bed exit/edge warnings in relation to the duration of activation of the bed exit module. The data collection on the secondary endpoints1-8 is performed analogously to the primary endpoint as a mixed-methods approach at different time points or in different time periods: ? End of phase 0 (T 0, approximately week 5-6): observation of one to two trainings of nursing staff on MoMo followed by a group discussion. ? Accompanying during the use of MoMo (phase 1, weeks 7-24): accompanying study diary for anonymous recording of situational challenges in the use of MoMo. ? After the end of the 18-week MoMo use phase (T 1.1, approximately week 25-30): online survey of nursing staff. ? After the end of the 18-week MoMo use phase (T 1.2, approximately week 26-35): One to two group discussions with nursing staff. The secondary endpoints 9 and 10 will be collected by means of prevalence surveys and the use of device data: ? Phase 0 (weeks 1-6): daily anonymized prevalence survey of the number of patients with cognitive impairment and adverse bed exit tendencies

Countries

Germany

Contacts

Public ContactSven Ziegler

Universitätsklinikum FreiburgPflegedirektionProjektkoordinatorPflegepraxiszentrum Freiburg

sven.ziegler@uniklinik-freiburg.de0761 / 270 - 19023

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026